Advisory & Strategy
Ethical strategy for brain health in serious neurological illness
We work with foundations and health systems to design patient-centered care for people living with serious neurological illness, including neurodegenerative diseases.
Our work applies established palliative care principles to the clinical, ethical, and decisional complexity unique to neurological illness.
Brain Health Strategy Group is an advisory practice focused on ethical strategy for brain health in serious illness. We work with foundations, health systems, and academic partners to design and evaluate models of care for people living with neurodegenerative and other serious neurological conditions.
We specialize in translating challenges of autonomy, capacity, communication, and care across the disease trajectory into practical frameworks, care pathways, and tools that support patients, families, and clinicians.
Our focus is not on service delivery, but on program design, ethical guidance, and field-building work that improves quality of care and supports dignity, agency, and goal-concordant decision-making.
Design and evaluation of care models for people living with neurodegenerative diseases and other serious neurological conditions. We develop care pathways, referral frameworks, and quality metrics that integrate palliative principles into neurological care from diagnosis through end of life.
Practical frameworks for navigating capacity, consent, communication, and goal-concordant care in neurological illness. We translate complex ethical questions into usable guidance for clinicians, institutions, and policy—including advance care planning and end-of-life decision-making.
Strategic support for brain health initiatives addressing women's cognitive health, caregiving, aging, and care in resource-limited settings. We help organizations design culturally grounded, sustainable approaches to brain health across populations and contexts.
We are typically engaged when neurological care presents ethical complexity and system-level gaps that require deliberate, patient-centered solutions.
Organizations typically reach out when they're asking: How do we improve care for people with neurodegenerative disease—not just fund research? How can we support autonomy and dignity when capacity and function diverge? How do we help clinicians navigate ethically difficult decisions with confidence?
We welcome inquiries about advisory engagements, program design, ethics consultation, and educational partnerships.